Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Clinical trial NCT06228924 · RECRUITING

Trial details

NCT number

NCT06228924

Sponsor

Tenaya Therapeutics

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2024-03-26

Primary completion

2026-05-01

Enrollment

15

View on ClinicalTrials.gov